Patent details

EP2679678 Title: Factor VII polypeptides that are modified and uses thereof

Basic Information

Publication number:
EP2679678
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP131621740
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Factor VII polypeptides that are modified and uses thereof
French Title of Invention:
Polypeptides du facteur VII modifiés et leurs utilisations
German Title of Invention:
Modifizierte Faktor-VII-Polypeptide und Verwendungen dafür
SPC Number:

Dates

Filing date:
10/04/2009
Grant date:
18/05/2016
EP Publication Date:
18/05/2016
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/01/2014
EP B1 Publication Date:
18/05/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
10/04/2017
Expiration date:
10/04/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/04/2009
 
 

Name:
Catalyst Biosciences Inc.
Address:
260 Littlefield Avenue, South San Francisco, CA 94080, United States (US)

Inventor

1

Name:
Madison Edwin
Address:
United States (US)

2

Name:
Thanos Christopher
Address:
United States (US)

Priority

Priority Number:
124021 P
Priority Date:
11/04/2008
Priority Country:
United States (US)

Classification

Main IPC Class:
C12N 9/64;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages